May 31 - June 4 | Chicago, IL | Booth 10113
MMIT’s team of experts will be onsite at the 2024 American Society of Clinical Oncology annual meeting in Chicago. We’re excited to share how the right data, insights and expertise can improve access to oncology therapies.
Visit us at Booth 10113!
MMIT integrates and unifies medical and pharmacy claims, lab tests and results, EMR notes and other data with payer coverage and clinical pathways data, creating a holistic view of the oncology patient journey.
Our real-world data, insights and expertise can help you understand how oncology patients and their HCPs navigate community and inpatient settings and identify the drivers that can improve access to lifesaving therapies.
Payer Data Intelligence
MMIT’s Lab Data for Commercial Targeting provides a precise and comprehensive solution to help manufacturers promote their therapies to specific providers using lab test results before a diagnosis or prescribing decision is made.
Payer Data Intelligence
Strategic Launch Report provides drug manufacturers with a realistic view of payers’ coverage adoption rates and utilization management within the first year post-launch. The report is paired with consensus forecast data from our partner, Evaluate, for currently approved and pipeline agents within the target indication, to help you identify competitors and challenges and proactively plan your near- and long-term strategies.
Payer Data and Provider Insights
PULSE Analytics provides one of the most comprehensive and granular data sets to help pharma companies get the actionable insights they need to target critical provider accounts.
